Decreased lamina propria effector cell responsiveness to interleukin-10 in ileal Crohn's disease

被引:15
作者
Colpaert, S [1 ]
Vanstraelen, K
Liu, ZJ
Penninckx, F
Geboes, K
Rutgeerts, P
Ceuppens, J
机构
[1] Katholieke Univ Leuven Hosp, Expt Immunol Lab, Louvain, Belgium
[2] Katholieke Univ Leuven Hosp, Dept Abdominal Surg, Louvain, Belgium
[3] Katholieke Univ Leuven Hosp, Dept Pathol, Louvain, Belgium
[4] Katholieke Univ Leuven Hosp, Dept Gastroenterol, Louvain, Belgium
[5] Katholieke Univ Leuven, Louvain, Belgium
关键词
IL-10; IL-10R; Crohn's disease; lamina propria;
D O I
10.1006/clim.2001.5149
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated whether a lack of IL-10 production or responsiveness could be involved in Crohn's disease pathogenesis. Lamina propria mononuclear cells, isolated from the ilea of Crohn's disease patients (n = 16) and controls (n = 13), were activated with anti-CD3 mAb in the presence of CD80 transfectants or LPS +/- IFN-gamma. No evidence for deficient IL-10 production by either T cells or macrophages in Crohn's disease was found. However, the efficacy of rhIL-10 to down-regulate IFN-gamma and especially TNF production in cell cultures from the involved tissues of Crohn's disease patients was poor, and the use of an anti-IL-10R mAb even provided evidence for proinflammatory effects of IL-10. This lack of IL-10 effect possibly results from IL-12 activity. We conclude that IL-10 exhibits poor anti- and even potential proinflammatory effects on ileal Crohn's disease lamina propria. These data might explain the lack of therapeutic efficacy when IL-10 is given to Crohn's disease patients. (C) 2001 Elsevier Science.
引用
收藏
页码:68 / 76
页数:9
相关论文
共 47 条
[1]   In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease [J].
Autschbach, F ;
Braunstein, J ;
Helmke, B ;
Zuna, I ;
Schürmann, G ;
Niemir, ZI ;
Wallich, R ;
Otto, HF ;
Meuer, SC .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (01) :121-130
[2]  
BENJAMIN D, 1992, BLOOD, V80, P1289
[3]   Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses [J].
Berg, DJ ;
Davidson, N ;
Kuhn, R ;
Muller, W ;
Menon, S ;
Holland, G ;
ThompsonSnipes, L ;
Leach, MW ;
Rennick, D .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) :1010-1020
[4]   Interleukin-10 dose-dependent regulation of CD4+ and CD8+ T cell-mediated graft-versus-host disease [J].
Blazar, BR ;
Taylor, PA ;
Panoskaltsis-Mortari, A ;
Narula, SK ;
Smith, SR ;
Roncarolo, MG ;
Vallera, DA .
TRANSPLANTATION, 1998, 66 (09) :1220-1229
[5]   INTERLEUKIN-10 DIFFERENTIALLY REGULATES B7-1 (CD80) AND B7-2 (CD86) EXPRESSION ON HUMAN PERIPHERAL-BLOOD DENDRITIC CELLS [J].
BUELENS, C ;
WILLEMS, F ;
DELVAUX, A ;
PIERARD, G ;
DELVILLE, JP ;
VELU, T ;
GOLDMAN, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (09) :2668-2672
[6]   ISOLATION AND FUNCTIONAL CHARACTERIZATION OF HUMAN INTESTINAL MUCOSAL LYMPHOID-CELLS [J].
BULL, DM ;
BOOKMAN, MA .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 59 (05) :966-974
[7]   INTERLEUKIN-10 (IL-10) INHIBITS THE RELEASE OF PROINFLAMMATORY CYTOKINES FROM HUMAN POLYMORPHONUCLEAR LEUKOCYTES - EVIDENCE FOR AN AUTOCRINE ROLE OF TUMOR-NECROSIS-FACTOR AND IL-1-BETA IN MEDIATING THE PRODUCTION OF IL-8 TRIGGERED BY LIPOPOLYSACCHARIDE [J].
CASSATELLA, MA ;
MEDA, L ;
BONORA, S ;
CESKA, M ;
CONSTANTIN, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2207-2211
[8]   INTERLEUKIN-10 (IL-10) UP-REGULATES IL-1 RECEPTOR ANTAGONIST PRODUCTION FROM LIPOPOLYSACCHARIDE-STIMULATED HUMAN POLYMORPHONUCLEAR LEUKOCYTES BY DELAYING MESSENGER-RNA DEGRADATION [J].
CASSATELLA, MA ;
MEDA, L ;
GASPERINI, S ;
CALZETTI, F ;
BONORA, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (05) :1695-1699
[9]  
CHANG TT, 1994, DIVERSITY, V10, P25
[10]  
CHEN WF, 1991, J IMMUNOL, V147, P528